The binary relationship between client and contract organisations is crucial in the development of cuttingedge animal health products and technologies. True collaboration, from inception to completion, guarantees a better end product. We call this process ‘Molecule-toMarket’ and it’s paying off for clients around the world searching for new solutions to diseases and conditions
impacting animal health. Doug Cleverly at Argenta discusses how effective and innovative partnerships in animal health development can be the collaboration.